Company: CERO
Filing Date: 2025-01-21
Form Type: S-1/A
Source: 0001213900-25-004742
Chunk: 285

Company: CERO THERAPEUTICS HOLDINGS, INC.
Filing Date: 2025-01-21
Form: S-1/A
Chunk 285
---
 Rights which the holder could have acquired if the holder had held the number of shares of Common Stock acquirable upon complete exercise of the Offered Common Warrants immediately before the record date, or, if no such record is taken, the date as of which the record holders of shares of Common Stock are to be determined, for the grant, issue or sale of such Purchase Rights. Fundamental Transactions In the event of a fundamental transaction, as described in the Offered Common Warrants and generally including any reorganization, recapitalization or reclassification of our Common Stock, the sale, transfer or other disposition of all or substantially all of our properties or assets, our consolidation or merger with or into another person, the consummation of a business combination with another person or group of persons whereby such other person or group acquires greater than 50.1% of the voting power of the outstanding Common Stock and preferred stock, the holders of the Offered Common Warrants will be entitled to receive upon exercise of the Offered Common Warrants the kind and amount of securities, cash or other property that the holders would have received had they exercised the Offered Common Warrants immediately prior to such fundamental transaction. Notwithstanding anything to the contrary, in the event of a Fundamental Transaction, the holder may require the Company or its successor to repurchase the Offered Common Warrants for its Black-Scholes Value (as defined in the Offered Common Warrants) in cash. This right can be exercised concurrently with, or within 30 days following, the consummation or public announcement of the transaction. If the Fundamental Transaction occurs outside the Company’s control, such as in a hostile takeover or an unapproved transaction, the holder is entitled to receive consideration equivalent in type and proportion to that offered to common stockholders, also calculated based on the Black-Scholes model. Additionally, if no consideration is offered to the Company’s stockholders in the transaction, the holder is deemed to receive common stock of the successor entity, preserving the Offered Common Warrants value. 181 Transferability Subject to applicable laws, the Offered Common Warrants may be offered for sale, sold, transferred or assigned. There is currently no trading market for the Offered Common Warrants and a trading market is not expected to develop. Rights as a Stockholder Except as otherwise provided in the Offered Common Warrants or by virtue of a holder’s ownership of shares of our Common Stock, the holders of the Offered Common Warrants do not have the rights or privileges of